KCNE1 and atrial fibrillation: For this purpose, many atrial-selective targets such as ISK, IK2P, IKur and IK,ACh are still being evaluated with the hope of establishing an atrial-selective anti-AF option with reasonable safety at the ventricular level and outside the heart.